Edition:
United States

Star Lake Bioscience Co Inc Zhaoqing Guangdong (600866.SS)

600866.SS on Shanghai Stock Exchange

4.35CNY
--
Change (% chg)

-- (--)
Prev Close
¥4.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,763,455
52-wk High
¥7.63
52-wk Low
¥4.34

Latest Key Developments (Source: Significant Developments)

Star Lake Bioscience to swing to loss in 2017
Tuesday, 30 Jan 2018 10:19pm EST 

Jan 31(Reuters) - Star Lake Bioscience Co Inc Zhaoqing Guangdong <600866.SS>:Sees 2017 net loss to be about 170 million yuan .Says 2016 net profit was 24.3 million yuan .  Full Article

Star Lake Bioscience's Chairman Resigns Due To Change In Job Role
Friday, 29 Dec 2017 05:51am EST 

Dec 29 (Reuters) - Star Lake Bioscience Co Inc Zhaoqing Guangdong <600866.SS>::SAYS CHAIRMAN MO SHIWEN RESIGNS DUE TO CHANGE IN JOB ROLE.  Full Article

Starlake Bioscience elects chairman and appoints general manager and CFO
Wednesday, 17 May 2017 06:05am EDT 

May 17(Reuters) - Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> ::* Says it elects Mo Shiwen as chairman.* Says it appoints Chen Wu as general manager.* Says it appoints Zhu Hua as CFO.  Full Article

Starlake Bioscience to withdraw delisting risk warning, share trade to halt on April 11
Monday, 10 Apr 2017 08:00am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> : Says it withdraws delisting risk warning from April 12 after it has returned to net profit in 2016 .Says share trade to halt on April 11, then will resume on April 12.  Full Article

Starlake Bioscience returns to profit, to scrap delisting risk warning
Thursday, 30 Mar 2017 09:18am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> : Says it returns to net profit of 24.3 million yuan ($3.53 million) in 2016 versus net loss of 422.4 million yuan year ago . Says it applies to Shanghai stock exchange to relist its bonds .Says it applies to Shanghai stock exchange to cancel delisting risk warning.  Full Article

Starlake Bioscience cancels acquisition plan for up to 35 pct stake in Guangzhou pharma
Tuesday, 28 Mar 2017 12:21am EDT 

Starlake Bioscience <600866.SS> :Says it canceled plan to buy up to 35 percent stake in a Guangzhou-based pharma company.  Full Article

Starlake Bioscience Co Inc Zhaoqing Guangdong sees 2016 Q1~Q3 net profit to be 15 mln yuan
Wednesday, 12 Oct 2016 06:02am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> :sees 2016 Q1~Q3 net profit to be 15 million yuan, while net loss of Q1~Q3 in 2015(175.2 million yuan).  Full Article

Starlake Bioscience Co Inc Zhaoqing Guangdong to buy 25 pct stake in financial leasing co
Wednesday, 17 Aug 2016 12:35am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> :Says it will buy 25 percent stake in a financial leasing co from an investment company, for 0 yuan.  Full Article

Starlake Bioscience Co Inc Zhaoqing Guangdong to sell units
Wednesday, 17 Aug 2016 12:24am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS> :Says it will sell two wholly owned units to an investment firm, for 68.6 million yuan and 21.4 million yuan respectively.  Full Article

Starlake Bioscience Co Inc Zhaoqing Guangdong expects H1 2016 net loss of 18 mln yuan
Saturday, 16 Jul 2016 07:33am EDT 

Starlake Bioscience Co Inc Zhaoqing Guangdong <600866.SS>: Says net loss for H1 of 2016 to be about 18 million yuan .Says the net loss of H1 of 2015 was 108 million yuan.  Full Article